Robin Michelet

46PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical mycologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jul 07, 2026
Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.

|Dec 15, 2025
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization.

Zrinka Duvnjak, Robin Michelet, Casper Steenholdt

|Nov 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).

Marian Klose, Ilaria Colombo, Katrin Gobat

|Nov 13, 2025
The β-lactamase inhibitor concentration-dependent minimum inhibitory concentration (MICcBLI) as methodology to assess the pharmacokinetic/pharmacodynamic relationship of piperacillin/tazobactam for dosing optimization.

Malin Andersson, Franz Weber, Ferdinand Weinelt

|Jul 27, 2025
Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy.

Davide Bindellini, Robin Michelet, Yersultan Mirasbekov

|Dec 10, 2024
A minimal physiologically-based pharmacokinetic modeling platform to predict intratumor exposure and receptor occupancy of an anti-LAG-3 monoclonal antibody.

Robin Michelet, Klas Petersson, Marc C Huisman

Pageof 8

Frequent Collaborators

13 joint publications

Wilhelm Huisinga

9 joint publications

Gerd Mikus

9 joint publications

Anna Mueller-Schoell

7 joint publications

Charlotte Kloft